Takahiko Kurasawa Selected Research

Immunoglobulin G (IgG)

1/2012

A case of multiple giant coronary aneurysms and abdominal aortic aneurysm coexisting with IgG4-related disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takahiko Kurasawa Research Topics

Disease

9	Rheumatoid Arthritis 01/2021 - 10/2011
3	Vasculitis (Vasculitides) 01/2021 - 10/2017
3	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021 - 10/2017
2	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 12/2019 - 10/2017
2	Lupus Nephritis 01/2013 - 01/2013
1	Type IV Ehlers-Danlos Syndrome 01/2022
1	Blood Vessel Dissection 01/2022
1	Aneurysm (Aneurysms) 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Polyarteritis Nodosa (Periarteritis Nodosa) 01/2021
1	Giant Cell Arteritis (Horton Disease) 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Hemorrhage 01/2021
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2021
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2020
1	Glomerulonephritis 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Microscopic Polyangiitis 10/2017
1	Rheumatic Diseases (Rheumatism) 06/2016
1	Hyperuricemia 01/2013
1	Adult-Onset Still's Disease 03/2012
1	Arthralgia (Joint Pain) 03/2012
1	Fever (Fevers) 03/2012
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2012
1	Immunoglobulin G4-Related Disease 01/2012
1	Drug-Related Side Effects and Adverse Reactions 10/2011
1	Pneumonia (Pneumonitis) 10/2011

Drug/Important Bio-Agent (IBA)

8	tocilizumab (atlizumab)FDA Link 01/2020 - 10/2011
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2012
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2017 - 01/2013
3	Infliximab (Remicade)FDA Link 06/2016 - 07/2014
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 01/2020
2	GlucocorticoidsIBA 01/2020 - 01/2013
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 01/2013
2	Interleukin-6 (Interleukin 6)IBA 06/2016 - 03/2012
2	Methotrexate (Mexate)FDA LinkGeneric 06/2016 - 07/2014
1	Collagen Type III (Type III Collagen)IBA 01/2022
1	VaccinesIBA 01/2021
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 01/2021
1	ChAdOx1 nCoV-19IBA 01/2021
1	BNT162 VaccineIBA 01/2021
1	Rheumatoid FactorIBA 01/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	C-Reactive ProteinIBA 01/2021
1	IntegrinsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2020
1	InterleukinsIBA 01/2020
1	Etanercept (Enbrel)FDA Link 10/2015
1	CytokinesIBA 10/2015
1	Antirheumatic Agents (DMARD)IBA 07/2014
1	Tumor Necrosis Factor InhibitorsIBA 05/2014
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 05/2014
1	EnzymesIBA 01/2013
1	mizoribineIBA 01/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2013
1	Adalimumab (Humira)FDA Link 06/2012
1	Ferritins (Ferritin)IBA 03/2012
1	Immunoglobulin G (IgG)IBA 01/2012

Therapy/Procedure

4	Therapeutics 05/2018 - 01/2012